Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy
Background: Chemoradiotherapy (CRT) for head and neck cancer (HNC) induces side-effects, including trismus, which impairs quality of life by causing difficulty to eat, speak, and maintain good oral hygiene, and by altering social life. Given the wide variation of reported trismus prevalence and as a...
Main Authors: | Kerstin Faravel PT, MSc, Marta Jarlier MSc, Pierre Senesse MD, PhD, Marie-Eve Huteau MSc, Chloé Janiszewski MSc, Anne Stoebner MD, Pierre Boisselier MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2023-01-01
|
Series: | Integrative Cancer Therapies |
Online Access: | https://doi.org/10.1177/15347354221147283 |
Similar Items
-
Response to Somay et al. Letter to the Editor Regarding “Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy”
by: Kerstin Faravel PT, MSc, et al.
Published: (2023-04-01) -
In Regard to Faravel et al. 2022: “Trismus Occurrence and Link With Radiotherapy Doses in Head and Neck Cancer Patients Treated With Chemoradiotherapy”
by: Efsun Somay PhD, et al.
Published: (2023-04-01) -
The role of exercise therapy in managing post-radiotherapy trismus in head and neck cancer
by: Yousef E. Ezzat, MDS, et al.
Published: (2021-02-01) -
Deep learning auto-segmentation and automated treatment planning for trismus risk reduction in head and neck cancer radiotherapy
by: Maria Thor, et al.
Published: (2021-07-01) -
A simple protocol for in vivo dosimetry in radiotherapy of head and neck tumor using portal imaging
by: Nickfarjam A (MSc), et al.
Published: (2010-03-01)